Search

John William Madsen

from Lebanon, NJ
Age ~68
Get Report
Also known as:
John W Madsen, John J Madsen, John W Adsen, John W Pierce
Related to:
Robert W Pierce, 53Leah J P, 46Rebekah L P, 49Madelynn NorthropPaula Lapp, 56Freddie Lapp
Connected to:
Annika Madsen, 30Arne B Madsen, 85Barry Madsen, 75Becky L Madsen, 62Brock L Madsen, 62Camrie B Madsen, 32Camron A Madsen, 45Christina E Madsen, 44Colby B Madsen, 37Dawna S Madsen, 38

John Madsen Phones & Addresses

  • Lebanon, NJ
  • 4409 Canton Ave, Jefferson, MD 21755 (301) 473-5445
  • 2900 Camille Dr, College Sta, TX 77845 (979) 704-0068
  • College Station, TX
  • Bryan, TX
  • Knoxville, MD
  • Bronx, NY

Work

Position: Professional/Technical

Education

Degree: High school graduate or higher

Public records

Vehicle Records

John Madsen

View page
Address:
4409 Canton Ave, Jefferson, MD 21755
Phone:
(301) 473-5445
VIN:
WDBRF87J37F853968
Make:
MERCEDES-BENZ
Model:
C-CLASS
Year:
2007

Business Records

Name / Title
Company / Classification
Phones & Addresses
Mr. John Madsen
General Manager
Madsen Motors
Auto/Truck Dealers-New & Used
50 King Street, Box 549, Sioux Lookout, ON P8T 1A8
(807) 737-1450, (807) 737-2523
John O. Madsen
President
Superior Signs Ltd
Signs
2225 Coquitlam Ave, Port Coquitlam, BC V3B 1J6
(604) 942-6636
John Madsen
Secretary Treasurer
Westar Financial Inc
Financing
220-2899 Broadmoor Blvd, Sherwood Park, AB T8H 1B5
(780) 467-7600, (780) 467-7612
John Madsen
Director
West Shore U-Lock Mini Storage Ltd.
Western Communities U-Lock Storage Ltd.
Storage-Household & Commercial. Moving Services-Labor & Materials
1621 Island Highway, Victoria, BC V9B 1H8
(250) 478-8767, (604) 541-8537
John O. Madsen
President
Superior Signs Ltd
Signs
(604) 942-6636
John Madsen
Director
West Shore U-Lock Mini Storage Ltd
Storage-Household & Commercial · Moving Services-Labor & Materials
(250) 478-8767, (604) 541-8537
John Madsen
Director
Hudson Trail Outfitters, Ltd
Ret Sporting Goods · Ret Sporting Goods/Bicycles
8525 Atlas Dr, Gaithersburg, MD 20877
(301) 840-0650
John R. Madsen
Director
John R. Madsen PC

Publications

Amazon

The Northern Tucson Basin Survey: Research Directions And Background Studies (Asm Archaeological Series)

The Northern Tucson Basin Survey: Research Directions and Background Studies (ASM Archaeological Series)

View page

Introduces the research design and project goals for this survey, including environmental backgrounds, results of two large site reconnaissance projects, and focused reports on projectile points, ceramics, and isolated artifacts.
Binding

Paperback

Pages

283

Publisher

Arizona State Museum

ISBN #

1889747475

EAN Code

9781889747477

ISBN #

9

Isbn (Books And Publications)

The Marana Community in the Hohokam World

View page
Author

John H. Madsen

ISBN #

0816513147

Pronunciacion Del Espanol: Lengua Hablada Y Literaria

View page
Author

John Kuhlmann Madsen

ISBN #

8470394835

Us Patents

Methods And Compositions For Inhibition Of Angiogenesis With Em-138

View page
US Patent:
6518298, Feb 11, 2003
Filed:
Feb 20, 2001
Appl. No.:
09/788872
Inventors:
Shawn J. Green - Vienna VA
Jamshed H. Shah - Columbia MD
John Madsen - Knoxville MD
Robert J. DAmato - Cambridge MA
Assignee:
Entremed, Inc. - Rockville MD
International Classification:
A61K 3140
US Classification:
514416
Abstract:
The present invention comprises a group of compounds that effectively inhibit angiogenesis. More specifically, the invention comprises the compound EM-138 and its use in the inhibition of angiogenesis and treatment of angiogenesis associate diseases, including the inhibition of tumor growth and metastasis.

Analogs Of 2-Phthalimidinoglutaric Acid

View page
US Patent:
6673828, Jan 6, 2004
Filed:
May 11, 1999
Appl. No.:
09/309464
Inventors:
Shawn J. Green - Vienna VA
Jamshed H. Shah - Columbia MD
John Madsen - Knoxville MD
William Fogler - Rockville MD
Assignee:
Childrens Medical Center Corporation - Boston MA
International Classification:
A61K 314035
US Classification:
514416, 548472
Abstract:
The invention provides new and useful analogs of 2-phthalimidinoglutaric acid. These analogs include DL-2-methyl-2-phthalimidinoglutaric acid and hydroxylated analogs of 2-phthalimidinoglutaric. The invention also provides processes for making these analogs. The invention also provides the two individual enantiomers of DL-2-methyl-2-phthalimidinoglutaric acid, (R)-(+)-2-methyl-2-phthalimidinoglutaric acid and (S)-(-)-2-methyl-2-phthalimidinoglutaric acid, and processes for separating these individual enantiomers from the racemate. Further, the invention provides methods for inhibiting angiogenesis and treating angiogenesis-associated diseases, including cancer and macular degeneration, by administering one or more of these compounds.

Method Of Producing And Purifying Angiostatin

View page
US Patent:
6723536, Apr 20, 2004
Filed:
Oct 18, 2001
Appl. No.:
09/982516
Inventors:
John Madsen - Jefferson MD
Hong Liang - Gaithersburg MD
Kim Lee Sim - Gaithersburg MD
Xinhua Zhou - North Potomac MD
Renee J. Boerner - Apex NC
Lourdes L. Bermejo - Morrisville NC
Firoz R. Mistry - Chapel Hill NC
Jeffrey L. Schrimsher - Hillsborough NC
Scot R. Shepard - Clayton NC
Jeremy Johnston - Durham NC
Assignee:
EntreMed, Inc. - Rockville MD
International Classification:
C12N 1500
US Classification:
435 691, 530350, 536 231, 43525423
Abstract:
The present invention provides a method for recombinant production, recovery and purification of angiostatin protein. This method may be employed for large scale recovery and purification of recombinantly-produced angiostatin protein.

Compositions And Methods For Treating Cancer And Hyperproliferative Disorders

View page
US Patent:
6805865, Oct 19, 2004
Filed:
Mar 11, 1999
Appl. No.:
09/266543
Inventors:
John W. Holaday - Bethesda MD
Antonio Ruiz - Gaithersburg MD
John Madsen - Jefferson MD
Stacy M. Plum - Arlington VA
Assignee:
EntreMed, Inc. - Rockville MD
International Classification:
A61K 39395
US Classification:
4241851, 4241541, 4241941, 42419511, 4241981
Abstract:
Compositions and methods effective for eliciting an immune response for inhibiting abnormal or undesirable cell proliferation, particularly endothelial cell proliferation and angiogenesis related to neovascularization and tumor growth are provided. The compositions comprise a naturally occurring or synthetic protein, peptide, or protein fragment containing all or an active portion of a growth factor in a pharmaceutically acceptable carrier. The preferred growth factors comprise basic fibroblast growth factor and vascular endothelial growth factor. The methods involve administering to a human or animal the compositions described herein in a dosage sufficient to elicit an- immune response. The methods are useful for treating diseases and processes mediated by undesired and uncontrolled cell proliferation, such as cancer, particularly where uncontrolled cell proliferation is influenced by the presence of growth factors. Administration of the composition to a human or animal having metastasized tumors is useful for preventing the growth or expansion of such tumors.

Methods Of Treating Undesired Angiogenesis With 2-Methyl-Em-138

View page
US Patent:
7112602, Sep 26, 2006
Filed:
Dec 9, 2003
Appl. No.:
10/732867
Inventors:
Robert J. D'Amato - Lexington MA, US
Shawn J. Green - Vienna VA, US
John W. Madsen - Jefferson MD, US
William Fogler - Rockville MD, US
Jamshed H. Shah - Brookeville MD, US
Assignee:
The Children's Medical Center Corporation - Boston MA
International Classification:
A61K 31/40
US Classification:
514416
Abstract:
The invention provides new and useful analogs of 2-phthalimidinoglutaric acid. These analogs include DL-2-methyl-2-phthalimidinoglutaric acid and hydroxylated analogs of 2-phthalimidinoglutaric. The invention also provides processes for making these analogs. The invention also provides the two individual enantiomers of DL-2-methyl-2-phthalimidinoglutaric acid, (R)-(+)-2-methyl-2-phthalimidinoglutaric acid and (S)-(−)-2-methyl-2-phthalimidinoglutaric acid, and processes for separating these individual enantiomers from the racemate. Further, the invention provides methods for inhibiting angiogenesis and treating angiogenesis-associated diseases, including cancer and macular degeneration, by administering one or more of these compounds.

Method Of Producing And Purifying Endostatin Protein

View page
US Patent:
7476726, Jan 13, 2009
Filed:
Sep 14, 2000
Appl. No.:
10/070560
Inventors:
Hong Liang - Gaithersburg MD, US
Kim Lee Sim - Gaithersburg MD, US
Xinhua Zhou - North Potomac MD, US
John Madsen - Jefferson MD, US
Renee J. Boerner - Apex NC, US
Firoz Rustom Mistry - Chapel Hill NC, US
Scot R. Shepard - Clayton NC, US
Jeffrey L. Schrimsher - Hillsborough NC, US
Lourdes L. Bermejo - Raleigh NC, US
Assignee:
The Children's Medical Center Corp. - Boston MA
Covance Biotechnology Services, Inc. - Cary NC
International Classification:
A23J 1/00
C07K 1/00
C12N 15/00
C12N 1/20
C12N 1/00
US Classification:
530416, 530412, 530413, 530414, 530417, 530350, 4353201, 4352523, 43525423
Abstract:
The present invention provides a method for recombinant production, recovery and purification of endostatin protein. This method may be employed for large scale recovery and purification of recombinantly-produced endostatin protein.

Methods And Compositions For Treating An Ocular Neovascular Disease

View page
US Patent:
7524865, Apr 28, 2009
Filed:
Jul 21, 2004
Appl. No.:
10/896780
Inventors:
Robert J. D'Amato - Cambridge MA, US
Shawn J. Green - Vienna VA, US
Jamshed H. Shah - Columbia MD, US
John Madsen - Knoxville MD, US
Assignee:
Celgene Corporation - Summit NJ
International Classification:
A61K 31/445
US Classification:
514323
Abstract:
The present invention comprises a group of compounds that effectively inhibit angiogenesis. More specifically, the invention comprises the compound EM-138 and its use in the inhibition of angiogenesis and treatment of angiogenesis associate diseases, including the inhibition of tumor growth and metastasis.

Vaccines Against Sterols

View page
US Patent:
20020018808, Feb 14, 2002
Filed:
May 1, 2001
Appl. No.:
09/846776
Inventors:
Carl Alving - Bethesda MD, US
Julie Kenner - Silver Springs MD, US
Glenn Swartz - Jessup MD, US
John Madsen - Knoxville MD, US
International Classification:
A61K039/00
A61K009/127
A61K031/739
A01N043/04
US Classification:
424/450000, 424/184100, 514/054000
Abstract:
The present invention relates to immunoreactive compositions and methods for immunizing humans or animals against sterols, such as cholesterol and its derivatives, and their use in methods for reducing the serum cholesterol levels of the immunized individuals and to retard or reduce the severity of atherosclerosis or atherosclerosis plaques caused by ingestion of dietary cholesterol. Another embodiment of the present invention encompasses ergosterol or ergosterol derivative compositions useful for the treatment or prevention of fungal infection, and methods of use thereof. Yet another aspect of the invention is dairy products containing anti-ergosterol antibodies produced by dairy animals immunized against ergosterol according to the present invention and methods of making thereof. A further aspect of the invention is a diagnostic assay for determining whether a human or animal has a fungal infection.
Control profile
John William Madsen from Lebanon, NJ, age ~68 Get Report